Material Review Board (MRB) in Quality Management Systems: Meaning, Process, and Role in Controlled Nonconformance Decisions

Every manufacturing operation eventually produces a defective part or out-of-spec material. What separates quality-driven organizations from reactive ones is what happens next. A Material Review Board (MRB) answers that question with structure, accountability, and documented logic  bringing the right people together to make controlled, defensible nonconformance decisions.

Without a functioning MRB process, quality decisions happen informally. A supervisor overrides an inspection failure without documentation. Someone on the floor approves a questionable component because production is behind schedule. These shortcuts create massive compliance and liability exposure  the kind that surfaces during FDA audits, AS9100 surveillance reviews, or customer quality investigations.

This article covers what a Material Review Board is, how the MRB process works, who participates, what disposition types mean, and how digital QMS platforms are reshaping the way quality teams execute nonconformance management.

What Is a Material Review Board (MRB)?

A Material Review Board is a cross-functional body responsible for evaluating nonconforming material and determining its final disposition. The MRB reviews materials, components, or finished goods that fail inspection, deviate from specifications, or fall outside established quality standards.

The MRB does not simply flag problems  it resolves them through a controlled, documented process that satisfies both internal quality requirements and external regulatory demands.

Within a Quality Management System (QMS), the Material Review Board sits directly inside the nonconformance management framework. When a Nonconformance Report (NCR) is raised, the MRB takes ownership of evaluating the defect and deciding the appropriate path forward.

ISO 9001:2015 Clause 8.7 specifically addresses the control of nonconforming outputs. It requires organizations to identify, document, and control materials that do not meet requirements. The MRB is the operational mechanism that fulfills this requirement.

The term “material review board” is most common in aerospace, defense, automotive, and medical device manufacturing. However, the concept applies to any regulated industry that handles physical materials and products.

Core MRB functions include:

• Reviewing inspection failures and production deviations
• Evaluating the technical feasibility of rework, repair, or use-as-is dispositions
• Approving or rejecting proposed nonconformance dispositions
• Documenting decisions with full traceability back to the originating NCR
• Triggering corrective actions when systemic nonconformance patterns emerge

Why the Material Review Board Matters Across Regulated Industries

The MRB serves several simultaneous purposes. Quality teams value it for compliance assurance. Operations teams rely on it for decision speed. Finance teams depend on it for cost control. Each function carries a direct stake in MRB outcomes.

Protects Product Safety and Regulatory Compliance. No organization should release a nonconforming product without a documented review. The MRB creates a formal gate that prevents unauthorized use of defective materials. Under FDA 21 CFR Part 820, traceability of nonconforming product handling is not optional  it is a mandatory quality system requirement.

Reduces Production Risk. When a defective component surfaces mid-production, every passing hour carries escalating risk. An effective MRB process resolves disposition decisions quickly and prevents the spread of nonconforming material into other production streams.

Controls Scrap and Rework Costs. Scrapping a component costs money. Reworking it costs labor. Accepting it as-is carries regulatory risk. The MRB weighs all three options against technical and compliance realities  preventing both under-reaction and expensive over-reaction.

Maintains Audit Readiness. Auditors from certification bodies and regulatory agencies look specifically at how organizations handle nonconforming material. A robust MRB process produces clear documentation, authorization signatures, and closure records that demonstrate a functioning QMS rather than just a documented one.

Supports End-to-End Traceability. Every MRB decision links to a specific material batch, NCR record, and approval chain. This traceability supports root cause analysis, supplier quality management, and long-term trend identification.

Standards, including IATF 16949 for automotive and ISO 13485 for medical devices,s build their nonconforming product requirements on this same foundation of documented, traceable, cross-functional review.

Material Review Board Process: Step-by-Step

The MRB process follows a defined sequence. Each step feeds the next. Skipping steps creates compliance gaps and increases the likelihood of poor disposition decisions.

Step 1  Identification of Nonconforming Material

An inspector, operator, or automated system flags material that fails the specification. Detection can occur at incoming inspection, in-process quality checks, or final inspection. The finding must be documented immediately  verbal identification without a written record does not satisfy QMS requirements.

Step 2  Quarantine and Segregation

The flagged material moves to a designated hold area. Physical segregation prevents accidental use in production. Tags or labels mark the material clearly as nonconforming and awaiting MRB review. This step is non-negotiable in AS9100 and ISO 13485 environments.

Step 3  NCR Creation and Documentation

A Nonconformance Report (NCR) captures the full details: part number, lot, quantity, nature of the defect, detection point, and initial findings. This document serves as the official quality record and triggers the MRB workflow in the QMS.

Step 4  MRB Review Meeting and Evaluation

The cross-functional team assembles  physically or digitally  to review the NCR and evaluate the nonconforming material. The team examines defect severity, quantity affected, potential customer impact, and regulatory implications before any disposition discussion begins.

Step 5  Engineering and Quality Assessment

Engineering assesses whether the material can be reworked, repaired, or used without restoring full specification conformance. Quality assurance evaluates the compliance risk of each option. Both functions provide documented input before any disposition is finalized.

Step 6  Disposition Decision

The MRB reaches a consensus disposition decision. This decision must be documented and signed by authorized personnel. In regulated industries, the authorization chain matters as much as the decision itself  an unsigned disposition record is a compliance gap.

Step 7  Execution of Disposition

The team executes the approved decision. Scrapped material is destroyed and documented. Rework moves back into production under controlled conditions with re-inspection required. Use-as-is material receives formal concession documentation. Returned material goes back to the supplier with written justification.

Step 8  Final Documentation and QMS Closure

The NCR closes with complete documentation: disposition rationale, authorization signatures, material status, and any corrective actions triggered. The QMS record is complete, linked, and audit-ready.

MRB Disposition Types: What They Mean

The Material Review Board has five primary disposition outcomes. Each carries different implications for cost, compliance, and product integrity. Scrap means permanent removal of nonconforming material from the production stream. The team determines that the material cannot be corrected or accepted at any level. Scrapped material must be destroyed or rendered unusable to prevent reintroduction. This is the safest disposition from a compliance standpoint but carries the highest direct cost.

Rework involves correcting nonconforming material to bring it back into full conformance with the original specification. The rework process must be documented, and the material re-inspected after correction. Both AS9100 and ISO 9001 require a reworked product to pass the same acceptance criteria as the originally conforming product.

Repair differs from rework in an important way. Rework restores full specification compliance. Repair modifies the material to a functional, acceptable state but may not fully restore the original specification. Repair dispositions require customer or engineering approval and carry additional documentation requirements in aerospace and medical device environments.

Use-As-Is (Concession) means the MRB approves the nonconforming material for release without any correction. This decision requires strong engineering justification that the deviation does not affect safety, function, or regulatory compliance. Many standards and customer contracts require written customer approval before any use-as-is disposition on critical components.

Return to Vendor (RTV) applies when the defect originates with the supplier. The MRB directs the return of the nonconforming material to the vendor. This outcome feeds the supplier quality management process and typically triggers a formal corrective action request to the supplier.

Understanding the difference between these dispositions matters. A team that reflexively scraps everything wastes money. One that routinely accepts use-as-is without rigorous MRB evaluation creates compliance and product safety risk.

Who Participates in the Material Review Board?

The MRB draws its value from cross-functional representation. No single department holds all the information needed to make sound disposition decisions.

Quality Assurance owns the MRB process. QA professionals schedule meetings, maintain the NCR log, ensure documentation completeness, and verify that every decision meets applicable quality standard requirements. They serve as the compliance gatekeepers throughout the MRB workflow.

Engineering evaluates the technical impact of the nonconformance. Engineers determine whether rework is feasible, whether a use-as-is disposition creates functional risk, and whether a deviation from specification affects downstream assembly or end-product performance. Their technical judgment typically drives the final disposition.

Production and Operations brings the floor perspective. Operations teams assess rework feasibility from a scheduling and process capability standpoint. They also identify whether a defect pattern suggests a process problem rather than an isolated event.

Supply Chain and Procurement participates when the nonconformance involves incoming material from a supplier. Procurement manages supplier communication, coordinates returns, and initiates supplier corrective action requests when appropriate.

Regulatory Affairs  in highly regulated industries like medical devices or pharmaceuticals  joins the MRB for high-risk dispositions. Regulatory representatives evaluate whether the deviation creates reportable events or impacts product labeling and existing approvals.

The ASQ framework for quality management emphasizes that MRB authority must be clearly defined. Members need documented authorization to approve specific disposition types. This structure prevents unauthorized decisions and establishes clear accountability during audit situations.

MRB vs. CAPA vs. Deviation Management: Key Differences

These three quality processes are related but distinct. Confusing them creates process gaps, compliance failures, and wasted effort.

MRB  What do we do with this material right now? The MRB focuses on the immediate question: what happens to this specific batch of nonconforming material? It is reactive and time-sensitive. The MRB does not investigate root causes  it makes controlled disposition decisions with full documentation.

CAPA  Why did this happen, and how do we prevent recurrence? Corrective and Preventive Action addresses the systemic cause behind the nonconformance. A CAPA investigates root cause, implements a corrective fix, and verifies effectiveness over time. Where the MRB resolves the material in front of you, CAPA resolves the process failure that produced it.

Deviation Management  Was this a planned or unplanned departure? Deviation management addresses situations where a process, method, or specification was intentionally or unintentionally departed from. A deviation may trigger an MRB if it results in nonconforming material. An MRB outcome may trigger a CAPA if the nonconformance reveals a systemic failure.

The relationship works like this: a deviation triggers an MRB when material status becomes uncertain. The MRB makes a disposition decision. If that decision reveals a pattern or systemic failure, it triggers a CAPA. If the chosen disposition requires a process change, it moves through Management of Change (MOC). These are distinct workflows that feed each other  not interchangeable processes.

Organizations that treat MRB and CAPA as the same process create audit findings. ISO 9001 corrective action requirements and FDA quality system regulations treat them as separate, linked obligations.

MRB Documentation and Audit Requirements

Documentation is where MRB processes succeed or fail under regulatory scrutiny. The disposition decision matters, but auditors want to see the evidence trail that supports it.

Every MRB record must capture:

• Description and nature of the nonconformance
• Quantity and identification of affected material
• Date of detection and source (incoming, in-process, or final inspection)
• Evaluation findings from each participating functional area
• Disposition decision with documented justification
• Authorization signatures of all required approvers

Approval Signatures and Authorization. Under FDA 21 CFR Part 820, the Device History Record (DHR) must reflect all nonconforming product handling. Under AS9100, use-as-is and repair dispositions may require customer approval and formal documentation.

Full NCR-to-Closure Traceability. Every MRB record must link to its originating NCR. Auditors trace this chain directly. A disposition record without a linked NCR  or an NCR without a documented disposition  creates a compliance gap that can jeopardize certification status.

Record Retention. ISO 9001:2015 requires organizations to retain documented information as evidence of conformity. FDA regulations require device manufacturers to retain quality records for specified periods, often tied to the device’s expected lifespan. Organizations should establish retention policies that satisfy the most stringent applicable requirement across all relevant standards.

Electronic Records. Organizations moving to digital MRB workflows must ensure their systems meet applicable electronic record requirements. For FDA-regulated environments, 21 CFR Part 11 governs electronic record integrity, audit trail requirements, and electronic signature validity. Platforms like eLeaP QMS support these requirements with built-in audit trails and role-based approval workflows.

MRB Metrics and KPIs for Continuous Quality Improvement

Measuring MRB performance turns reactive nonconformance management into proactive quality improvement. These KPIs give quality teams the data they need to identify bottlenecks, reduce waste, and demonstrate QMS effectiveness.

MRB Turnaround Time measures the average time from NCR creation to MRB disposition decision. Long turnaround times indicate process bottlenecks, scheduling problems, or insufficient staffing for review activities. Reducing turnaround time directly reduces hold-area backlog and production disruption.

Scrap Rate Percentage tracks the proportion of nonconforming material receiving a scrap disposition. High scrap rates may signal incoming material quality issues, process instability, or overly conservative disposition criteria. Trending scrap rates by supplier, part number, or process step reveals targeted improvement opportunities.

Rework Cost Impact captures the direct labor and material costs associated with rework dispositions. Tracking rework costs by defect type, production stage, and supplier identifies where prevention investments generate the greatest return.

NCR Closure Rate tracks the percentage of open NCRs that close within the defined target timeframe. A low closure rate signals MRB process inefficiency or documentation backlogs. High closure rates indicate a responsive, well-managed nonconformance program.

Repeat Nonconformance Rate tracks how often the same defect type recurs after a disposition decision. High recurrence rates suggest that MRB decisions are not triggering appropriate corrective actions or that the linked CAPA process is underperforming.

These metrics align directly with Six Sigma quality improvement frameworks and operational excellence benchmarks used across regulated manufacturing environments.

Digital Transformation of the MRB Process in Modern QMS Software

Traditional MRB processes run on paper forms, email chains, and shared spreadsheets. This approach works at low volumes but breaks down as organizations scale. Digital QMS platforms are fundamentally reshaping how quality teams execute MRB workflows.

Automated NCR Routing. Modern QMS platforms automatically route NCRs to the appropriate MRB team members based on material type, defect classification, or risk level. This eliminates the manual scheduling bottleneck and ensures the right people receive the right information immediately.

Digital Approval Chains with Audit Logs. Digital MRB workflows capture every review action with a timestamp, user identity, and electronic signature. This creates an immutable audit trail that satisfies requirements under ISO 9001, AS9100, and FDA 21 CFR Part 11. Chasing paper signatures during an audit becomes a problem of the past.

ERP and MES Integration. When MRB decisions connect directly to ERP and Manufacturing Execution Systems, disposition actions execute automatically. A scrap decision updates inventory records instantly. A rework decision triggers a production work order. This integration eliminates the manual handoff errors that create downstream quality problems.

Real-Time Dashboards and Analytics. Quality managers gain visibility into open NCRs, pending MRB decisions, turnaround times, and disposition trends through real-time dashboards. This visibility supports both daily operational decisions and strategic quality improvement planning.

eLeaP QMS delivers these capabilities within an integrated platform that connects nonconformance management, CAPA, document control, and training management. Teams managing MRB workflows in eLeaP benefit from seamless handoffs between all connected quality processes.

Best Practices for Effective Material Review Board Implementation

Organizations that run high-performing MRB processes share a consistent set of practices.

Define Clear Disposition Criteria. Document specific guidance for each disposition type. Defect severity qualifies for use-as-is? What rework methods are pre-approved? What defects automatically go to scrap? Clear criteria reduce decision inconsistency and accelerate the review cycle.

Build Escalation Rules for High-Risk Cases. Not all nonconformances carry equal risk. Safety-critical defects, regulatory-reportable deviations, and customer-visible failures should trigger an elevated MRB review with additional functional representation and documentation requirements.

Train MRB Members Consistently. Every MRB participant needs to understand the applicable quality standards, the organization’s disposition criteria, and their specific role in the process. Documented training records support audit readiness and ensure informed decision-making across the board.

Ensure Regulatory Alignment. The MRB process must reflect the requirements of every applicable standard. Aerospace organizations need AS9100-aligned workflows. Medical device manufacturers need FDA 21 CFR Part 820 alignment. Automotive suppliers need IATF 16949 compliance. Periodic review of MRB procedures against current regulatory requirements prevents compliance drift over time.

Connect MRB Outcomes to CAPA Triggers. Define the criteria that escalate an MRB outcome to a formal CAPA. Recurrent defects, high-cost scrap events, and safety-related dispositions should automatically trigger root cause investigation. This linkage transforms the MRB from a reactive resolution tool into a continuous quality improvement driver.

Conclusion: The Strategic Role of the Material Review Board

The Material Review Board is not a procedural checkbox. It is a strategic quality control mechanism that protects product integrity, reduces compliance exposure, and enables cost-disciplined decisions about nonconforming materials.

When organizations run MRB processes with discipline  cross-functional participation, documented decisions, clear disposition criteria, and strong CAPA linkage  they build a quality management system that performs under audit pressure and improves over time.

The shift toward digital MRB workflows removes the manual bottlenecks that have historically slowed nonconformance resolution. Automated routing, electronic approvals, ERP integration, and real-time analytics give quality teams the speed and visibility they need to manage nonconformances without sacrificing compliance integrity.

eLeaP QMS supports this evolution with an integrated platform built for the demands of regulated manufacturing environments. Organizations that embed the Material Review Board within a connected QMS gain a compounding advantage: faster disposition decisions, stronger documentation, lower scrap costs, and a quality system that continuously learns from its own nonconformance data.

Explore how eLeaP QMS can streamline your nonconformance management and Material Review Board workflows. Connect your MRB, CAPA, document control, and training processes in one integrated quality management platform.